Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Vitamin D receptor, HER-2 polymorphisms and risk of prostate cancer in men with benign prostate hyperplasia.

Saudi medical journal - 1 Apr 2004

Tayeb Mohammed T, Clark Caroline, Haites Neva E, Sharp Linda, Murray Graeme I, McLeod Howard L

Abstract excerpt

OBJECTIVE: Prostate cancer (PRCa) is one of the most common causes of cancer death in men and determinants of PRCa risk remain largely unidentified. Benign prostatic hyperplasia (BPH) is found in the majority of ageing men and has been associated with PRCa. Many candidate genes have been suggested to be involved in PRCa, such as those that are central to cellular growth and differentiation in the prostate gland....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Case-Control Studies
Share to Genes, erbB-2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Polymorphism, Genetic

Share to Prostatic Hyperplasia

Share to Prostatic Neoplasms

Share to Receptors, Calcitriol

Share to Risk Factors

Source

Identifiers

PMID: 15083213

Genes

VDR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Vitamin D receptor, HER-2 polymorphisms and risk of prostate cancer in men with benign prostate hyperplasia.PMID 15083213Read ↗

CYP3A4 and VDR gene polymorphisms and the risk of prostate cancer in men with benign prostate hyperplasia.Semantic proximity Read ↗

Association between vitamin D receptor gene polymorphisms and genetic susceptibility to benign prostatic hyperplasia: A systematic review and meta-analysis.Semantic proximity Read ↗

CYP3A4 promoter variant is associated with prostate cancer risk in men with benign prostate hyperplasia.Semantic proximity Read ↗

Association of genetic variants of the vitamin D receptor (VDR) gene (Fok-I, Taq-I and Bsm-I) with susceptibility of benign prostatic hyperplasia in a North Indian population.Semantic proximity Read ↗

Vitamin D receptor gene polymorphism and prostate cancer risk.Semantic proximity Read ↗

Meta-analysis of vitamin D receptor gene polymorphisms and benign prostatic hyperplasia risk.Semantic proximity Read ↗

Systematic review and meta-analysis of candidate gene association studies of benign prostate hyperplasia.Semantic proximity Read ↗

Association of benign prostate hyperplasia with polymorphisms in VDR, CYP17, and SRD5A2 genes among Lebanese men.Semantic proximity Read ↗

Significance of vitamin D receptor gene polymorphism for risk and disease severity of prostate cancer and benign prostatic hyperplasia in Japanese.Semantic proximity Read ↗

Length and somatic mosaicism of CAG and GGN repeats in the androgen receptor gene and the risk of prostate cancer in men with benign prostatic hyperplasia.Semantic proximity Read ↗

Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSASemantic proximity Read ↗

Polymorphisms in genes involved in sex hormone metabolism may increase risk of benign prostatic hyperplasia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.